AIMS: The pathogenesis of endocarditis is not well understood resulting in unsuccessful attempts at prevention. Clinical observations suggest that Staphylococcus aureus infects either damaged or inflamed heart valves. Using a newly developed endocarditis mouse model, we therefore studied the initial adhesion of S. aureus in both risk states. METHODS AND RESULTS: Using 3D confocal microscopy, we examined the adhesion of fluorescent S. aureus to murine aortic valves. To mimic different risk states we either damaged the valves with a surgically placed catheter or simulated valve inflammation by local endothelium activation. We used von Willebrand factor (VWF) gene-deficient mice, induced platelet and fibrinogen depletion and used several S. aureus mutant strains to investigate the contribution of both host and bacterial factors in early bacterial adhesion. Both cardiac valve damage and inflammation predisposed to endocarditis, but by distinct mechanisms. Following valve damage, S. aureus adhered directly to VWF and fibrin, deposited on the damaged valve. This was mediated by Sortase A-dependent adhesins such as VWF-binding protein and Clumping factor A. Platelets did not contribute. In contrast, upon cardiac valve inflammation, widespread endothelial activation led to endothelial cell-bound VWF release. This recruited large amounts of platelets, capturing S. aureus to the valve surface. Here, neither fibrinogen, nor Sortase A were essential. CONCLUSION: Cardiac valve damage and inflammation predispose to S. aureus endocarditis via distinct mechanisms. These findings may have important implications for the development of new preventive strategies, as some interventions might be effective in one risk state, but not in the other. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The pathogenesis of endocarditis is not well understood resulting in unsuccessful attempts at prevention. Clinical observations suggest that Staphylococcus aureus infects either damaged or inflamed heart valves. Using a newly developed endocarditis mouse model, we therefore studied the initial adhesion of S. aureus in both risk states. METHODS AND RESULTS: Using 3D confocal microscopy, we examined the adhesion of fluorescent S. aureus to murine aortic valves. To mimic different risk states we either damaged the valves with a surgically placed catheter or simulated valve inflammation by local endothelium activation. We used von Willebrand factor (VWF) gene-deficient mice, induced platelet and fibrinogen depletion and used several S. aureus mutant strains to investigate the contribution of both host and bacterial factors in early bacterial adhesion. Both cardiac valve damage and inflammation predisposed to endocarditis, but by distinct mechanisms. Following valve damage, S. aureus adhered directly to VWF and fibrin, deposited on the damaged valve. This was mediated by Sortase A-dependent adhesins such as VWF-binding protein and Clumping factor A. Platelets did not contribute. In contrast, upon cardiac valve inflammation, widespread endothelial activation led to endothelial cell-bound VWF release. This recruited large amounts of platelets, capturing S. aureus to the valve surface. Here, neither fibrinogen, nor Sortase A were essential. CONCLUSION: Cardiac valve damage and inflammation predispose to S. aureus endocarditis via distinct mechanisms. These findings may have important implications for the development of new preventive strategies, as some interventions might be effective in one risk state, but not in the other. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Thomas Vanassche; Willy E Peetermans; Marie-Christine Herregods; Paul Herijgers; Peter Verhamme Journal: Expert Rev Cardiovasc Ther Date: 2011-09
Authors: Michael E Powers; Russell E N Becker; Anne Sailer; Jerrold R Turner; Juliane Bubeck Wardenburg Journal: Cell Host Microbe Date: 2015-06-10 Impact factor: 21.023
Authors: Mark J Dayer; Simon Jones; Bernard Prendergast; Larry M Baddour; Peter B Lockhart; Martin H Thornhill Journal: Lancet Date: 2014-11-18 Impact factor: 79.321
Authors: Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Laurens Liesenborghs; Marijke Peetermans; Jorien Claes; Tiago Rafael Veloso; Christophe Vandenbriele; Maarten Criel; Marleen Lox; Willy E Peetermans; Simon Heilbronner; Philip G de Groot; Thomas Vanassche; Marc F Hoylaerts; Peter Verhamme Journal: J Infect Dis Date: 2016-01-06 Impact factor: 5.226
Authors: Glenn W Gibson; Steven C Kreuser; Janet M Riley; Wendy S Rosebury-Smith; Cynthia L Courtney; Paul L Juneau; John M Hollembaek; Tong Zhu; Michael D Huband; David W Brammer; Joan K Brieland; Mark C Sulavik Journal: Comp Med Date: 2007-12 Impact factor: 0.982
Authors: Manli Na; Zhicheng Hu; Majd Mohammad; Mariana do Nascimento Stroparo; Abukar Ali; Ying Fei; Anders Jarneborn; Peter Verhamme; Olaf Schneewind; Dominique Missiakas; Tao Jin Journal: mBio Date: 2020-11-17 Impact factor: 7.867
Authors: Christian Johann Lerche; Franziska Schwartz; Marie Theut; Emil Loldrup Fosbøl; Kasper Iversen; Henning Bundgaard; Niels Høiby; Claus Moser Journal: Front Cell Dev Biol Date: 2021-06-18